Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014

We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiotos, Kathleen, Ross, Rachael K., Han, Jennifer H., Miller, Matthew, Gerber, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407215/
https://www.ncbi.nlm.nih.gov/pubmed/28470018
http://dx.doi.org/10.1093/ofid/ofx039
_version_ 1783232105844572160
author Chiotos, Kathleen
Ross, Rachael K.
Han, Jennifer H.
Miller, Matthew
Gerber, Jeffrey S.
author_facet Chiotos, Kathleen
Ross, Rachael K.
Han, Jennifer H.
Miller, Matthew
Gerber, Jeffrey S.
author_sort Chiotos, Kathleen
collection PubMed
description We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and appendectomy was a common indication for carbapenem therapy.
format Online
Article
Text
id pubmed-5407215
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54072152017-05-03 Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014 Chiotos, Kathleen Ross, Rachael K. Han, Jennifer H. Miller, Matthew Gerber, Jeffrey S. Open Forum Infect Dis Brief Report We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and appendectomy was a common indication for carbapenem therapy. Oxford University Press 2017-03-09 /pmc/articles/PMC5407215/ /pubmed/28470018 http://dx.doi.org/10.1093/ofid/ofx039 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Brief Report
Chiotos, Kathleen
Ross, Rachael K.
Han, Jennifer H.
Miller, Matthew
Gerber, Jeffrey S.
Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title_full Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title_fullStr Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title_full_unstemmed Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title_short Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
title_sort use of carbapenems, polymyxins, and tigecycline in united states children’s hospitals, 2010–2014
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407215/
https://www.ncbi.nlm.nih.gov/pubmed/28470018
http://dx.doi.org/10.1093/ofid/ofx039
work_keys_str_mv AT chiotoskathleen useofcarbapenemspolymyxinsandtigecyclineinunitedstateschildrenshospitals20102014
AT rossrachaelk useofcarbapenemspolymyxinsandtigecyclineinunitedstateschildrenshospitals20102014
AT hanjenniferh useofcarbapenemspolymyxinsandtigecyclineinunitedstateschildrenshospitals20102014
AT millermatthew useofcarbapenemspolymyxinsandtigecyclineinunitedstateschildrenshospitals20102014
AT gerberjeffreys useofcarbapenemspolymyxinsandtigecyclineinunitedstateschildrenshospitals20102014

Ejemplares similares